Recombitek C3 - 1331.R1
21 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
21
Total Reports
0
Deaths Reported
0.0%
Death Rate
Active Ingredients
Recombitek C3 - 1331.R1
Administration Routes
SubcutaneousUnknown
Species Affected
Dog 21
Most Affected Breeds
Crossbred Canine/dog 4
Retriever - Golden 2
Retriever - Labrador 2
Pug 2
Bulldog 2
Deutsche Dogge, Great Dane 1
Beagle 1
Hound (unspecified) 1
Spitz - German Pomeranian 1
Poodle - Standard 1
Most Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 10
Vomiting 9
Injection site pain 5
Not eating 3
Injection site swelling 3
Decreased appetite 2
Drooling 2
Shaking 2
Hyperaesthesia 2
No sign 1
Facial swelling (see also 'Skin') 1
Reluctant to move 1
Outcome Breakdown
Recovered/Normal
11 (52.4%)
Outcome Unknown
8 (38.1%)
Ongoing
2 (9.5%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.